Atrás
43
Rango del Día
$367.87
$367.90
Rango de 52 Semanas
$362.28
$535.75
Volumen
1
Promedio 50D / 200D
$383.12
/
$435.98
Cierre Anterior
$367.90
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 57.4 | 0.2 |
| P/B | 7.4 | 3.0 |
| ROE % | 13.5 | 3.6 |
| Net Margin % | 11.7 | 3.8 |
| Rev Growth 5Y % | 16.7 | 9.9 |
| D/E | 0.4 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$18.21
$16.86 – $18.81
|
1.02B | 1 |
| FY2029 |
$18.37
$17.01 – $18.97
|
932.81M | 1 |
| FY2028 |
$15.60
$14.44 – $16.11
|
801.81M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-11 | $11.44 | $12.79 | +11.8% |
| 2025-05-20 | N/A | $2.36 | — |
| 2024-12-31 | N/A | $2.21 | — |
| 2024-11-13 | $3.34 | $1.39 | -58.4% |
| 2024-06-30 | N/A | $1.33 | — |
| 2024-06-26 | N/A | $3.38 | — |
| 2023-12-31 | N/A | $1.79 | — |
| 2023-11-15 | N/A | $2.92 | — |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.31%
Growth (3Y)
30.45%
Growth (5Y)
45.42%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jul 07, 2025 | Jul 08, 2025 | $1.39 | 0.33% |
| Jul 02, 2024 | Jul 03, 2024 | $1.11 | 0.31% |
| Jul 03, 2023 | Jul 05, 2023 | $1.45 | 0.97% |
| Jul 04, 2022 | Jul 06, 2022 | $0.62 | 0.42% |
| Jul 07, 2021 | Jul 09, 2021 | $0.63 | 0.42% |
| Jul 08, 2020 | Jul 10, 2020 | $0.21 | 0.14% |
| Jul 03, 2019 | Jul 05, 2019 | $0.56 | 0.37% |
| Jul 03, 2018 | Jul 05, 2018 | $1.41 | 0.94% |
| Jul 04, 2017 | Jul 06, 2017 | $1.35 | 0.90% |
| Jul 05, 2016 | Jul 07, 2016 | $1.02 | 0.68% |
| Jul 06, 2015 | Jul 08, 2015 | $0.64 | 0.42% |
| Jul 07, 2014 | Jul 10, 2014 | $0.34 | 0.22% |
| Jul 08, 2013 | Jul 11, 2013 | $0.21 | 0.14% |
| Jul 09, 2012 | Jul 12, 2012 | $0.20 | 0.14% |
| Jul 12, 2011 | Jul 15, 2011 | $0.24 | 0.16% |
Puntos Clave
Revenue grew 16.71% annually over 5 years — strong growth
ROE of 13.49% — decent returns on equity
Debt/Equity of 0.39 — conservative balance sheet
Negative free cash flow of -128.95M
P/E of 57.37 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 19.83%
Crecimiento
Revenue Growth (5Y)
16.71%
Revenue (1Y)36.54%
Earnings (1Y)11.66%
FCF Growth (3Y)N/A
Calidad
Return on Equity
13.49%
ROIC8.94%
Net Margin11.68%
Op. Margin15.07%
Seguridad
Debt / Equity
0.39
Current Ratio0.86
Interest Coverage16.99
Valoración
P/E Ratio
57.37
Forward P/E30.70
P/B Ratio7.39
EV/EBITDA46.53
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.54% | Revenue Growth (3Y) | 22.69% |
| Earnings Growth (1Y) | 11.66% | Earnings Growth (3Y) | 30.64% |
| Revenue Growth (5Y) | 16.71% | Earnings Growth (5Y) | 96.99% |
| Profitability | |||
| Revenue (TTM) | 748.87M | Net Income (TTM) | 87.50M |
| ROE | 13.49% | ROA | 6.58% |
| Gross Margin | 39.00% | Operating Margin | 15.07% |
| Net Margin | 11.68% | Free Cash Flow (TTM) | -128.95M |
| ROIC | 8.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.39 | Current Ratio | 0.86 |
| Interest Coverage | 16.99 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.31% |
| Dividend Growth (3Y) | 30.45% | Dividend Growth (5Y) | 45.42% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 57.37 | Forward P/E | 30.70 |
| P/B Ratio | 7.39 | P/S Ratio | 6.70 |
| PEG Ratio | 4.28 | Forward PEG | N/A |
| EV/EBITDA | 46.53 | Fwd EV/EBITDA | 30.59 |
| Forward P/S | 6.92 | Fwd Earnings Yield | 3.26% |
| FCF Yield | -2.57% | ||
| Market Cap | 5.02B | Enterprise Value | 5.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 748.87M | 548.46M | 497.46M | 464.84M | 403.66M |
| Net Income | 87.50M | 78.37M | 51.28M | 23.11M | 5.81M |
| EPS (Diluted) | 6.41 | 5.74 | 3.82 | 1.82 | 0.46 |
| Gross Profit | 292.07M | 189.05M | 140.59M | 113.82M | 94.83M |
| Operating Income | 112.85M | 86.22M | 37.30M | 24.40M | 769,000.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.33B | 1.10B | 861.88M | 756.91M | 717.68M |
| Total Liabilities | 650.66M | 483.66M | 291.57M | 356.63M | 313.54M |
| Shareholders' Equity | 679.69M | 617.73M | 562.33M | 392.54M | 395.39M |
| Total Debt | 267.00M | 256.00M | 157.00M | 267.00M | 215.00M |
| Cash & Equivalents | 36.50M | 74.02M | 24.48M | 15.86M | 18.15M |
| Current Assets | 426.95M | 337.95M | 208.33M | 193.58M | 185.14M |
| Current Liabilities | 496.19M | 440.22M | 258.99M | 237.34M | 272.38M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#62 of 77
Actividad Reciente
Entró
Capital Heavy Grower
Mar 24, 2026